The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Survivin, cancer networks and pathway-directed drug discovery
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
Ambrosini, G., Adida, C., & Altieri, D. C. (1997) · Nature Medicine · doi:10.1038/nm0897-917 · Cited by 3,165
Self-citationEGF–ERBB signalling: towards the systems level
Citri, A., & Yarden, Y. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1962 · Cited by 2,004
Control of apoptosis and mitotic spindle checkpoint by survivin
Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C., & Altieri, D. C. (1998) · Nature · doi:10.1038/25141 · Cited by 1,870
Self-citationSawyers, C. (2004) · Nature · doi:10.1038/nature03095 · Cited by 1,165
Promoting apoptosis as a strategy for cancer drug discovery
Fesik, S. W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1736 · Cited by 1,098
The Connectivity Map: A new tool for biomedical research
Lamb, J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2044 · Cited by 945
Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family
Eckelman, B. P., Salvesen, G. S., & Scott, F. L. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400795 · Cited by 813
Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53
Hoffman, W. H., Biade, S., Zilfou, J. T., Chen, J., & Murphy, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106643200 · Cited by 794
Analysis of human transcriptomes
Velculescu, V. E., Madden, S. L., Zhang, L., Lash, A. E., Yu, J., Rago, C., Lal, A., Wang, C. J., Beaudry, G. A., Ciriello, K. M., et al. (1999) · Nature Genetics · doi:10.1038/70487 · Cited by 774
Structural basis for phosphoserine-proline recognition by group IV WW domains.
Verdecia, M. A., Bowman, M. E., Lu, K. P., Hunter, T. R., & Noel, J. P. (2000) · Nature Structural Biology · doi:10.1038/77929 · Cited by 704
Regulation of apoptosis at cell division by p34 cdc2 phosphorylation of survivin
O'Connor, D. S., Grossman, D., Plescia, J., Li, F., Zhang, H., Villa, A., Tognin, S., Marchisio, P. C., & Altieri, D. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240390697 · Cited by 611
Self-citationPleiotropic cell-division defects and apoptosis induced by interference with survivin function
Li, F., Ackermann, E. J., Bennett, C. F., Rothermel, A. L., Plescia, J., Tognin, S., Villa, A., Marchisio, P. C., & Altieri, D. C. (1999) · Nature Cell Biology · doi:10.1038/70242 · Cited by 600
Self-citationHeat shock protein 90 as a molecular target for cancer therapeutics
Isaacs, J. S., Xu, W., & Neckers, L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00029-1 · Cited by 577
Gritsko, T., Williams, A., Turkson, J., Kaneko, S., Bowman, T., Huang, M., Nam, S., Eweis, I., Diaz, N., Sullivan, D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1752 · Cited by 563
Mirza, A., McGuirk, M., Hockenberry, T. N., Wu, Q., Ashar, H., Black, S., Wen, S. F., Wang, L., Kirschmeier, P., Bishop, W. R., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205353 · Cited by 530
Uren, A. G., Wong, L., Pakusch, M., Fowler, K. J., Burrows, F. J., Vaux, D. L., & Choo, K. H. A. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00769-7 · Cited by 527
Chromosomal passengers and the (aurora) ABCs of mitosis
Adams, R. R., Carmena, M., & Earnshaw, W. C. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01880-8 · Cited by 525
Survivin, a cancer target with an emerging role in normal adult tissues
Fukuda, S., & Pelus, L. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0375 · Cited by 465
Zhang, T., Otevrel, T., Gao, Z., Gao, Z., Ehrlich, S. M., Fields, J. Z., & Boman, B. M. (2001) · PubMed · Cited by 441
A role for survivin in chemoresistance of endothelial cells mediated by VEGF
Tran, J., Master, Z., Yu, J. L., Rak, J., Dumont, D. J., & Kerbel, R. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072586399 · Cited by 434
HBXIP functions as a cofactor of survivin in apoptosis suppression
Marusawa, H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg263 · Cited by 432
Sampath, S. C., Ohi, R., Leismann, O., Salic, A., Pozniakovski, A., & Funabiki, H. (2004) · Cell · doi:10.1016/j.cell.2004.06.026 · Cited by 422
Anti-apoptosis gene, survivin, and prognosis of neuroblastoma
Adida, C., Berrebi, D., Peuchmaur, M., Reyes-Mugica, M., & Altieri, D. C. (1998) · The Lancet · doi:10.1016/s0140-6736(05)70294-4 · Cited by 415
Self-citationMitochondrial survivin inhibits apoptosis and promotes tumorigenesis
Dohi, T., Beltrami, E., Wall, N. R., Plescia, J., & Altieri, D. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422222 · Cited by 405
Self-citationAn IAP-IAP Complex Inhibits Apoptosis
Dohi, T., Okada, K., Xia, F., Wilford, C. E., Samuel, T., Welsh, K., Marusawa, H., Zou, H., Armstrong, R., Matsuzawa, S.-I., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400236200 · Cited by 398
Self-citationSong, Z., Yao, X., & Wu, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300957200 · Cited by 363
Jeyaprakash, A. A., Klein, U. R., Lindner, D., Ebert, J., Nigg, E. A., & Conti, E. (2007) · Cell · doi:10.1016/j.cell.2007.07.045 · Cited by 351
Rational design of shepherdin, a novel anticancer agent
Plescia, J., Salz, W., Xia, F., Pennati, M., Zaffaroni, N., Daidone, M. G., Meli, M., Dohi, T., Fortugno, P., Nefedova, Y., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.035 · Cited by 341
Self-citationMorgillo, F., Woo, J. K., Kim, E. S., Hong, W. K., & Lee, H.-Y. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1684 · Cited by 338
Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement.
Noel, J. P., Verdecia, M. A., Huang, H.-K., Sonnenburg, E. D., Kaiser, D. A., & Hunter, T. R. (2000) · Nature Structural Biology · doi:10.1038/76838 · Cited by 337
Cancer gene therapy using a survivin mutant adenovirus
Mesri, M., Wall, N. R., Li, J., Kim, R. W., & Altieri, D. C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12983 · Cited by 337
Self-citationInhibition of CDK1 as a potential therapy for tumors over-expressing MYC
Goga, A., Yang, D., Tward, A. D., Morgan, D. O., & Bishop, J. M. (2007) · Nature Medicine · doi:10.1038/nm1606 · Cited by 326
Survivin and molecular pathogenesis of colorectal cancer
Kim, P. J., Plescia, J., Clevers, H., Fearon, E. R., & Altieri, D. C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13910-4 · Cited by 323
Self-citationSurvivin is required for stable checkpoint activation in taxol-treated HeLa cells
Carvalho, A., Carmena, M., Sambade, C., Earnshaw, W. C., & Wheatley, S. P. (2003) · Journal of Cell Science · doi:10.1242/jcs.00612 · Cited by 319
Regulation of survivin function by Hsp90
Fortugno, P., Beltrami, E., Plescia, J., Fontana, J., Pradhan, D., Marchisio, P. C., Sessa, W. C., & Altieri, D. C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2434345100 · Cited by 318
Self-citationA p34cdc2 survival checkpoint in cancer
O'Connor, D. S., Wall, N. R., Porter, A. C. G., & Altieri, D. C. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00084-3 · Cited by 315
Self-citationSurvivin is required for a sustained spindle checkpoint arrest in response to lack of tension
Lens, S. M. A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg307 · Cited by 310
Fortugno, P., Wall, N. R., Giodini, A., O'Connor, D. S., Plescia, J., Padgett, K. M., Tognin, S., Marchisio, P. C., & Altieri, D. C. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.3.575 · Cited by 307
Self-citationNicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin
Dasgupta, P., Kinkade, R., Joshi, B., DeCook, C., Haura, E., & Chellappan, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509313103 · Cited by 295
The case for survivin as a regulator of microtubule dynamics and cell-death decisions
Altieri, D. C. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.08.015 · Cited by 284
Self-citationSpeliotes, E. K., Uren, A., Vaux, D., & Horvitz, H. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00023-x · Cited by 244
Phosphorylation of Caspase-9 by CDK1/Cyclin B1 Protects Mitotic Cells against Apoptosis
Allan, L. A., & Clarke, P. R. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.03.019 · Cited by 237
Chromosome Alignment and Segregation Regulated by Ubiquitination of Survivin
Vong, Q. P., Cao, K., Li, H. Y., Iglesias, P. A., & Zheng, Y. (2005) · Science · doi:10.1126/science.1120160 · Cited by 236
Nuclear and Cytoplasmic Survivin: Molecular Mechanism, Prognostic, and Therapeutic Potential
Stauber, R. H., Mann, W., & Knauer, S. K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0494 · Cited by 229
Fraser, A. G., James, C., Evan, G. I., & Hengartner, M. O. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80137-7 · Cited by 222
Molecular Requirements for Kinetochore-Associated Microtubule Formation in Mammalian Cells
Tulu, U. S., Fagerstrom, C., Ferenz, N. P., & Wadsworth, P. (2006) · Current Biology · doi:10.1016/j.cub.2006.01.060 · Cited by 218
Rescuing drug discovery: in vivo systems pathology and systems pharmacology
van der Greef, J., & McBurney, R. N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1904 · Cited by 209
Survivin splice variants regulate the balance between proliferation and cell death
Caldas, H., Jiang, Y., Holloway, M. P., Fangusaro, J., Mahotka, C., Conway, E. M., & Altura, R. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208350 · Cited by 199
Asanuma, H., Torigoe, T., Kamiguchi, K., Hirohashi, Y., Ohmura, T., Hirata, K., Sato, M., & Sato, N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0491 · Cited by 195
The case for Survivin as mitotic regulator
Lens, S. M., Vader, G., & Medema, R. H. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.08.016 · Cited by 184
Regulation of survivin expression by IGF-1/mTOR signaling
Vaira, V, Lee, C. W., Goel, H. L., Bosari, S., Languino, L. R., & Altieri, D. C. (2007) · Oncogene · doi:10.1038/sj.onc.1210094 · Cited by 182
Self-citationTsuruma, T., Hata, F., Torigoe, T., Furuhata, T., Idenoue, S., Kurotaki, T., Yamamoto, M., Yagihashi, A., Ohmura, T., Yamaguchi, K., et al. (2004) · Journal of Translational Medicine · doi:10.1186/1479-5876-2-19 · Cited by 181
Effects of Survivin Antagonists on Growth of Established Tumors and B7-1 Immunogene Therapy
Kanwar, J. R., Shen, W.-P., Kanwar, R. K., Berg, R. W., & Krissansen, G. W. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.20.1541 · Cited by 172
Xing, Z., Conway, E. M., Kang, C., & Winoto, A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031588 · Cited by 167
Estève, P.-O., Chin, H. G., & Pradhan, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407729102 · Cited by 165
Xia, W., Bisi, J., Strum, J. C., Liu, L.-H., Carrick, K., Graham, K. M., Treece, A. L., Hardwicke, M. A., Dush, M. K., Liao, Q., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2000 · Cited by 165
Wang, H.-W. (2002) · The EMBO Journal · doi:10.1093/emboj/21.11.2602 · Cited by 165
Wobser, M., Keikavoussi, P., Kunzmann, V., Weininger, M., Andersen, M. H., & Becker, J. C. (2006) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-005-0102-x · Cited by 162
Compartmentalized Phosphorylation of IAP by Protein Kinase A Regulates Cytoprotection
Dohi, T., Xia, F., & Altieri, D. C. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.004 · Cited by 160
Self-citationAberrant Regulation of Survivin by the RB/E2F Family of Proteins
Jiang, Y., Saavedra, H. I., Holloway, M. P., Leone, G., & Altura, R. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404496200 · Cited by 160
Xiang, R., Mizutani, N., Luo, Y., Chiodoni, C., Zhou, H., Mizutani, M., Ba, Y., Becker, J. C., & Reisfeld, R. A. (2005) · Cancer Research · doi:10.1158/0008-5472.553.65.2 · Cited by 158
Autologous Dendritic Cell Vaccines for Non–Small-Cell Lung Cancer
Hirschowitz, E. A., Foody, T., Kryscio, R., Dickson, L., Sturgill, J., & Yannelli, J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.074 · Cited by 158
Why we're losing the war on cancer (and how to win it).
Leaf, C. (2004) · PubMed · Cited by 156
Survivin Modulates Microtubule Dynamics and Nucleation throughout the Cell Cycle
Rosa, J., Canovas, P. M., Islam, A., Altieri, D. C., & Doxsey, S. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-08-0723 · Cited by 150
Self-citationWheatley, S. P., Henzing, A. J., Dodson, H., Khaled, W. T., & Earnshaw, W. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311299200 · Cited by 139
Activation of Cancer-Specific Gene Expression by the Survivin Promoter
Bao, R., Connolly, D. C., Murphy, M., Green, J., Weinstein, J. K., Pisarcik, D. A., & Hamilton, T. C. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.7.522 · Cited by 135
Jonkers, J., & Berns, A. J. M. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.12.002 · Cited by 133
Walter, D., Wissing, S., Madeo, F., & Fahrenkrog, B. (2006) · Journal of Cell Science · doi:10.1242/jcs.02902 · Cited by 132
Survivin Loss in Thymocytes Triggers p53-mediated Growth Arrest and p53-independent Cell Death
Okada, H., Bakal, C., Shahinian, A., Elia, A., Wakeham, A. C., Suh, W., Duncan, G. S., Ciofani, M., Rottapel, R. K., Zúñiga‐Pflücker, J. C., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032092 · Cited by 128
Essential Role for Survivin in Early Brain Development
Jiang, Y., de Bruin, A., Caldas, H., Fangusaro, J., Hayes, J., Conway, E. M., Robinson, M. L., & Altura, R. A. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1446-05.2005 · Cited by 123
Mollinari, C., Reynaud, C., Martineau-Thuillier, S. X. E. P., Monier, S., Kieffer‐Jaquinod, S., Garin, J., Andreassen, P. R., Boulet, A., Goud, B., Kleman, J.-P., et al. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00205-3 · Cited by 122
Idenoue, S., Hirohashi, Y., Torigoe, T., Sato, Y., Tamura, Y., Hariu, H., Yamamoto, M., Kurotaki, T., Tsuruma, T., Asanuma, H., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0817 · Cited by 122
Sandall, S. L., Severin, F. F., McLeod, I. X., Yates, J. R., Oegema, K., Hyman, A. A., & Desai, A. B. (2006) · Cell · doi:10.1016/j.cell.2006.09.049 · Cited by 121
The kinases aurora B and mTOR regulate the G1–S cell cycle progression of T lymphocytes
Song, J. J., Salek‐Ardakani, S., So, T., & Croft, M. (2006) · Nature Immunology · doi:10.1038/ni1413 · Cited by 120
Leung, C. G., Xu, Y., Mularski, B., Liu, H., Gurbuxani, S. K., & Crispino, J. D. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062395 · Cited by 116
cIAP1 Localizes to the Nuclear Compartment and Modulates the Cell Cycle
Samuel, T., Okada, K., Hyer, M. L., Welsh, K., Zapata, J. M., & Reed, J. C. (2005) · Cancer Research · doi:10.1158/0008-5472.210.65.1 · Cited by 115
Mechanisms of Mitotic Cell Death Induced by Chemotherapy-Mediated G2 Checkpoint Abrogation
Vogel, C., Hager, C., & Bastians, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2548 · Cited by 115
Cancer-specific activation of the survivin promoter and its potential use in gene therapy
Chen, J., Liu, J.-C., Shen, L., Rau, K.-M., Kuo, H.-P., Li, Y. M., Shi, D., Lee, Y.-C., Chang, K., & Hung, M. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700752 · Cited by 115
Solution Structure of Human Survivin and Its Binding Interface with Smac/Diablo
Sun, C. C., Nettesheim, D. G., Liu, Z., & Olejniczak, E. T. (2004) · Biochemistry · doi:10.1021/bi0485171 · Cited by 109
Regulation of mitochondrial Smac/DIABLO-selective release by survivin
Ceballos‐Cancino, G., Espinosa, M., Maldonado, V., & Meléndez-Zajgla, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210560 · Cited by 105
Targeted therapy by disablingcrossroadsignaling networks: the survivin paradigm
Altieri, D. C. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0436 · Cited by 103
Self-citationDeterin, a New Inhibitor of Apoptosis from Drosophila melanogaster
Jones, G., Jones, D., Zhou, L., Steller, H., & Chu, Y. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000369200 · Cited by 98
Shugoshin 2 Regulates Localization of the Chromosomal Passenger Proteins in Fission Yeast Mitosis
Vanoosthuyse, V., Prykhozhij, S. V., & Hardwick, K. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-10-0890 · Cited by 98
Zwerts, F., Lupu, F., Vriese, A. D., Pollefeyt, S., Moons, L., Altura, R. A., Jiang, Y., Maxwell, P. H., Hill, P., Oh, H., et al. (2007) · Blood · doi:10.1182/blood-2006-06-028068 · Cited by 83
Regulation of Survivin Stability by the Aryl Hydrocarbon Receptor-interacting Protein
Kang, B. H., & Altieri, D. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603175200 · Cited by 79
Self-citationSemba, S., Trapasso, F., Fabbri, M., McCorkell, K. A., Volinia, S., Druck, T., Iliopoulos, D., Pekarsky, Y., Ishii, H., Garrison, P. N., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209323 · Cited by 73
Activated Checkpoint Kinase 2 Provides a Survival Signal for Tumor Cells
Ghosh, J. C., Dohi, T., Raskett, C. M., Kowalik, T. F., & Altieri, D. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3095 · Cited by 66
Self-citationStem cell-associated genes are extremely poor prognostic factors for soft-tissue sarcoma patients
Taubert, H. W., Würl, P., Greither, T., Kappler, M., Bache, M., Bartel, F., Kehlen, A., Lautenschläger, C., Harris, L. C., Kaushal, D., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210530 · Cited by 53
Mitosis-Independent Survivin Gene Expression In vivo and Regulation by p53
Xia, F., & Altieri, D. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4537 · Cited by 52
Self-citationContribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines
Gu, L., Chiang, K., Zhu, N., Findley, H. W., & Zhou, M. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.03.007 · Cited by 35
Stoepel, J., Ottey, M., Kurischko, C., et al. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-04-0337 · Cited by 31
Cited by
Molecular mechanisms of cisplatin resistance
Galluzzi, L., Senovilla, L., Vitale, I., Michels, J., Martins, I., Kepp, O., Castedo, M., & Kroemer, G. (2012) · Oncogene · doi:10.1038/onc.2011.384 · Cited by 2,760
Targeting cellular metabolism to improve cancer therapeutics
Zhao, Y., Butler, E. B., & Tan, M. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.60 · Cited by 989
Bollrath, J., Phesse, T. J., von Burstin, V. A., Putoczki, T., Bennecke, M., Bateman, T., Nebelsiek, T., Lundgren-May, T., Canli, Ö., Schwitalla, S., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.002 · Cited by 946
Mitotic catastrophe: a mechanism for avoiding genomic instability
Vitale, I., Galluzzi, L., Castedo, M., & Kroemer, G. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3115 · Cited by 834
Death through a tragedy: mitotic catastrophe
Vakifahmetoglu, H., Olsson, M., & Zhivotovsky, B. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.47 · Cited by 700
Metadata
- Authors
- Altieri, D. C.
- Venue
- Nature Reviews Cancer
- Published
- 2008-01
- Volume
- 8
- Issue
- 1
- Pages
- 61-70
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2078374613
- Cited by
- 994
- References
- 94
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.